Anti-transcription intermediary factor-1γ/α/β antibody-positive dermatomyositis associated with multiple panniculitis lesions

Int J Rheum Dis. 2017 Nov;20(11):1831-1834. doi: 10.1111/1756-185X.12638. Epub 2015 Aug 10.

Authors

Koichi Yanaba¹, Katsumi Tanito¹, Yasuhito Hamaguchi², Hidemi Nakagawa¹

Affiliations

¹ Department of Dermatology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
² Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Tokyo, Japan.

PMID: 26258542
DOI: 10.1111/1756-185X.12638

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Antinuclear / blood
Antibodies, Antinuclear / immunology*
Biomarkers / blood
Biopsy
Dermatomyositis / complications
Dermatomyositis / diagnosis
Dermatomyositis / drug therapy
Dermatomyositis / immunology*
Female
Glucocorticoids / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Panniculitis / diagnosis
Panniculitis / drug therapy
Panniculitis / immunology*
Pol1 Transcription Initiation Complex Proteins / immunology*
Transcription Factors / immunology*
Treatment Outcome
Tripartite Motif-Containing Protein 28 / immunology*

Substances

Antibodies, Antinuclear
Biomarkers
Glucocorticoids
Immunosuppressive Agents
Pol1 Transcription Initiation Complex Proteins
RRN3 protein, human
TRIM33 protein, human
Transcription Factors
TRIM28 protein, human
Tripartite Motif-Containing Protein 28